The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•18 February 2026•

1 min read

Prenetics Completes $70M Sale of Insighta Stake to Tencent, Achieves Zero-Debt Status

Canadian flag, a plasma bag, and "GRIFOLS" text on an orange background with medical equipment, microscopes, and vials.

Prenetics Global Limited (NASDAQ: PRE) has successfully finalized the divestment of its 35% equity interest in Insighta to Tencent for $70 million in cash. This strategic move has significantly bolstered the company's financial position, bringing its total adjusted liquidity to $171.1 million. Notably, the transaction allows Prenetics to achieve a zero-debt balance sheet, providing a robust foundation for future operations. The company intends to utilize the proceeds to accelerate the global expansion of its flagship consumer health and longevity brand, IM8. This divestiture marks a pivotal shift in the company's strategy to concentrate resources on high-growth areas. Investors are viewing the massive cash infusion as a positive catalyst for the company's long-term valuation.